TESARO is an oncology-focused biopharmaceutical company.
TESARO is dedicated to improving the lives of cancer patients by developing and providing safer and more effective therapeutics and supportive care products.
Contact
TESARO Bio GmbH.
Poststrasse 6
6300 ZUG
Switzerland
| www.tesarobio.com
|
Kasha Witkos, Senior Vice President and Head of International Business at Alnylam Pharmaceuticals, shares her journey from academic researcher to global biotech leader, driven by personal family experience of chronic…
Philippe de Saab, Vice President, Vision Care at Bausch + Lomb, outlines the company’s strategy amid rising global demand for contact lenses. He highlights innovations in contact lenses, a localised…
Marcel Imwinkelried, CEO of Siegfried, leads a CDMO specialising in small molecules with comprehensive global manufacturing capabilities. His “Evolve Plus” strategy focuses on operational excellence, selective biologics growth, and disciplined…
Eight years after establishing its Swiss affiliate as a one-man operation, Accord Healthcare has built a strong position in one of Europe’s most competitive markets, with a focused strategy in…
Carl-Michael Simon, Country Manager for Mid-Size Markets at argenx, discusses how the company has grown from its Dutch and Belgian origins into a global biotech delivering precision medicines for autoimmune…
Dr. Dragan Grabulovski, CEO and co-founder of Araris, shared how his journey from co-founding Covagen to advising venture firms shaped his vision for building a platform-driven biotech company. He explained…
Henric Bjarke, CEO of Tenpoint Therapeutics with offices in Basel, Switzerland, highlights the company’s de-risked presbyopia program, strong team, and large global market. With a career spanning landmark launches like…
Ahead of the 50th anniversary of the World Health Organization’s Model List of Essential Medicines (EML) in 2027, Brendan Shaw explains how the EML has evolved from a basic guide for…
New Idorsia CEO Srishti Gupta is emphasising “financial discipline” as she looks to turn around the fortunes of one of Europe’s top biotechs. Challenging Times Gupta, who spent almost…
As Medinova marks 80 years since its founding in Zurich, General Manager Olga Lamua Olivar is charting the path forward for the boutique specialty pharma player. With a career spanning…
Amid structural reforms and shifting expectations across the Swiss healthcare system, Marco Caruso’s return to Medtronic marks a renewed focus on patient impact, equitable access, and long-term value. Speaking from…
With more than 20 years of experience in the pharmaceutical industry and a track record at companies such as MSD, Abbott (later AbbVie), Eisai and AstraZeneca, Stuart Head brings a…
See our Cookie Privacy Policy Here
